Concepedia

Christopher J. Borths

CJ

14

Publications

2.5K

Citations

12

H-Index

2000

Active since

Affiliations

Amgen (United States)(Current)

Pfizer (United States)

AbbVie (United States)

Christopher J. Borths is an author at Amgen (United States) specializing in organic chemistry, natural sciences, and medicine.

Top concepts

MedicineNatural SciencesOrganic ChemistryBiomolecular EngineeringChemistryEngineeringBiochemistryDrug DiscoveryCatalysisPharmacology

Publications per year

2000–2022

14

Publications

14

New Strategies for Organic Catalysis: The First Highly Enantioselective Organocatalytic Diels−Alder Reaction

Kateri A. Ahrendt, Christopher J. Borths, David W. C. MacMillan · Journal of the American Chemical Society · 2000 · 1.6K citations

Chemical Engineering, Organic Catalysis, Engineering +12

A Highly Efficient Palladium/Copper Cocatalytic System for Direct Arylation of Heteroarenes: An Unexpected Effect of Cu(Xantphos)I

Jinkun Huang, Johann Chan, Ying Chen et al. · Journal of the American Chemical Society · 2010 · 321 citations

SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

Kevin J. Hamblett, Allison P. Jacob, Jesse L. Gurgel et al. · Cancer Research · 2015 · 128 citations

Protein Secretion, Drug Targeting, Natural Sciences +15

Structural Characterization of a Monoclonal Antibody–Maytansinoid Immunoconjugate

Quanzhou Luo, Hyo Helen Chung, Christopher J. Borths et al. · Analytical Chemistry · 2015 · 57 citations

Immunocytochemical Technique, Immunology, Bioanalysis +17

Highly Selective Rhodium-Catalyzed Conjugate Addition Reactions of 4-Oxobutenamides

Jamie L. Zigterman, Jacqueline C. S. Woo, Shawn D. Walker et al. · The Journal of Organic Chemistry · 2007 · 53 citations

Arylboronic Acids, Engineering, Biochemistry +12

Rows per page

1–5 of 14